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A B S T R A C T
We previously reported that reelin, an extracellular matrix protein ﬁrst known for its key role in neuronal
migration, reduces the susceptibility to dextran sulphate sodium (DSS)-colitis. The aim of the current study was
to determine whether reelin protects from colorectal cancer and how reelin defends from colon pathology. In the
colon of wild-type and of mice lacking reelin (reeler mice) we have analysed the: i) epithelium cell renewal
processes, ii) morphology, iii) Sox9, Cdx2, Smad5, Cyclin D1, IL-6 and IFNγ mRNA abundance in DSS-treated
and untreated mice, and iv) development of azoxymethane/DSS-induced colorectal cancer, using histological
and real time-PCR methodologies. The reeler mutation increases colitis-associated tumorigenesis, with increased
tumours number and size. It also impairs the intestinal barrier because it reduces cell proliferation, migration,
diﬀerentiation and apoptosis; decreases the number and maturation of goblet cells, and expands the intercellular
space of the desmosomes. The intestinal barrier impairment might explain the increased susceptibility to colon
pathology exhibited by the reeler mice and is at least mediated by the down-regulation of Sox9 and Cdx2. In
response to DSS-colitis, the reeler colon increases the mRNA abundance of IL-6, Smad5 and Cyclin D1 and
decreases that of IFNγ, conditions that might result in the increased colitis-associated tumorigenesis found in the
reeler mice. In conclusion, the results highlight a role for reelin in maintaining intestinal epithelial cell home-
ostasis and providing resistance against colon pathology.
1. Introduction
The intestinal epithelium provides a protective barrier against a
broad spectrum of potentially lethal microorganisms and carcinogens
that are present in the intestinal lumen. From the outer to the inner
layer, the intestinal barrier is composed of gut microbiota; a mucus
layer secreted by goblet cells, especially thick in the colon, that contains
antimicrobial peptides and IgA; epithelial cells with its paracellular
pathway sealed, and the innate and adaptive immune cells [1]. The
epithelium is the foremost component of the intestinal barrier and its
rapid and controlled cell turnover allows to adjust the cell renewal
processes in response to intrinsic and extrinsic signals and to maintain
the integrity of the barrier. The epithelial cells are constantly generated
from multipotential stem cells located in the crypts. The progeny cells
diﬀerentiate as they move up to the surface epithelium and eventually
they are released into the intestinal lumen with a turnover time of 4 to
6 days. In the colon, the three main types of diﬀerentiated cells are
colonocytes, that have both absorptive and secretory functions; goblet
cells that secret a variety of factors, including proteins, trefoil factors
and mucins, all of which help to protect the mucosa from injury, and
enteroendocrine cells that secrete hormones that regulate gastro-
intestinal function [2]. Deregulation of epithelial homeostasis, such as
perturbations in the balance between cell production, diﬀerentiation
and shedding, compromises the epithelial barrier function and if the
integrity of the barrier is not re-established, intestinal disorders such as
inﬂammatory diseases, malignant tissue transformation and cancer
could occur (see [1] for a recent review).
In spite of the number of studies regarding colon epithelium
homeostasis, the molecular mechanisms involved in such process and in
those modiﬁed under pathological conditions are not precisely under-
stood. Normal homeostasis requires a cross talk between the epithelium
and mesenchymal cells, being the pericryptal myoﬁbroblasts one of the
most important sources of factors that regulate epithelium renewal
processes. The synthesis and secretion of various substances as well as
their expression of receptors for many of these substances, allow the
myoﬁbroblasts to orchestrate functions that ranged from the control of
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epithelial cell renewal and wound repair to participation in the un-
derlying pathophysiology that characterizes ulcerative colitis and col-
orectal cancer [3]. In addition, its strategic location between the epi-
thelium and mucosa immune system allows their direct interaction with
antigens that crossing the epithelial barrier.
We previously reported that the subepithelial myoﬁbroblasts of
rodent small [4,5] and large intestine [6] and of human colon [7] ex-
press reelin, an extracellular matrix protein that was ﬁrst known by its
function in brain development [8]. More recently we reported that the
mice colon responds to DSS-treatment up-regulating reelin and that the
absence of reelin (reeler mutation) exacerbates DSS-induced colitis
phenotype [6], suggesting that reelin protects from colon pathology.
The purpose of the present work was to determine whether reelin
protects from colon cancer development and to understand how reelin
provides resistance against colon pathology. We have used the colon of
wild-type and reeler mice and examined the consequences of reelin
absence on: 1) epithelium homeostasis, morphology and gene expres-
sion in DSS-treated and untreated animals and 2) tumour development
in response to azoxymethane/dextran sodium sulphate (AOM/DSS)-
treatment.
Preliminary reports of some of these results were published as ab-
stracts [9–11].
2. Materials and methods
2.1. Materials
The antibodies: anti-cleaved caspase-3 (Asp175) was obtained from
Cell Signaling, anti-BrdU (B2531) from Sigma-Aldrich, anti-Muc2
(Sc15334) and anti-carbonic anhydrase-1 from Santa Cruz
Biotechnology, Inc., and anti-chromogranin A (NB120-15160) from
Novus Biologicals. Biotinylated peroxidase-conjugated anti-mouse and
anti-rabbit IgG were obtained from Sigma-Aldrich. Unless otherwise
stated, the other reagents were obtained from Sigma-Aldrich, Spain.
2.2. Animals
Male and female wild-type and reeler mice (B6C3Fe) of one and
three month-old were used. Reeler (rl) mice have a spontaneous auto-
somal recessive mutation of reelin [8]. Heterozygous (rl+/rl−) mice
were purchased from Jackson Laboratories (Bar Harbor, ME), through
Charles River Laboratories, Spain. Wild-type (rl+/rl+) and homozygous
reeler (rl−/rl−) mice were obtained by heterozygous crossings. The
animals were housed in a 12:12 light-dark cycle and fed ad libitum with
Global 2019 extruded rodent diet (Harlan Ibérica S.L.) with free access
to tap water. Mice were genotyped by PCR analysis of genomic DNA as
described [6]. The mice were humanely handled and sacriﬁced by
cervical dislocation in accordance with the guidelines of the European
Union Council (Directive 2010/63/UE) concerning the protection of
experimental animals.
2.3. Experimental design
Epithelium homeostasis measurements (cell proliferation, migra-
tion, diﬀerentiation and apoptosis) and morphological studies were
performed in the absence of experimental-induced colon pathology.
Acute colitis was induced as previously described [6]. Brieﬂy, three
month-old wild-type and reeler mice were randomized into untreated
and DSS-treated groups, which received either water or water con-
taining 3% (wt/vol) DSS (40 kDa, TdB Consultancy, Uppsala, Sweden),
respectively, during 9 days. Fresh DSS solution was provided every day.
Daily, throughout the DSS-treatment, body weight, stool consistency
and presence of blood in feces were recorded to follow colitis devel-
opment. Following sacriﬁce, the murine colon was removed, opened
longitudinally, washed with ice-cold saline solution and subdivided into
proximal and distal regions. For PCR-measurements tissues were frozen
at −80 °C until used.
Tumours were induced on three month-old wild-type and reeler
mice by AOM/DSS, following the protocol of Okayasu et al. [12]. DSS-
treatment induces chronic colitis and the AOM accelerates tumorigen-
esis. A single intraperitoneal dose of 10 mg of AOM per kg body weight
was injected and 7 days later 1% (wt/vol) DSS was administered in the
drinking water during 4 days, followed by 14 days with tap water. The
DSS/tap water cycle was repeated three times. The clinical parameters
described above were recorded daily during the DSS-treatment. Fol-
lowing sacriﬁce, the colon was removed and examined for the presence
of tumours. The tumours were counted, their diameter measured and
removed from the colon by micro-dissection.
2.4. Immunostaining analysis
0.5 cm colon segments that were incubated in phosphate-buﬀered
saline solution (PBS) containing 4% paraformaldehyde at 4 °C over-
night. Immunostaining assays were performed on either 7 μm cryosec-
tions or 5 μm paraﬃn-embedded sections of intact colon as previously
described [5]. The slides containing the colon sections were incubated
with the indicated primary antibody at 4 °C, overnight. Antibody
binding was visualized with biotinylated anti IgG antibodies, at dilution
1:100, followed by immunoperoxidase staining. The Vectastain ABC
peroxidase kit (Vector) and 3,3′-diaminobenzidine were used. Controls
were carried out without primary antibody. The slides were rinsed,
mounted and photographed with a Zeiss Axioskop 40 microscope
equipped with a SPOT Insight V 3.5 digital camera. Acquired images
were analysed by using Spot Advance 3.5.4.1 program (Diagnostic In-
strument, Inc.). The magniﬁcation was 20 × 10.
2.5. Measurement of cell proliferation and migration rate
Epithelial cell proliferation and migration rates were quantiﬁed by
measuring the incorporation of 5-bromo deoxyuridine (BrdU) into
DNA. Mice received an intraperitoneal injection of BrdU (120 mg/Kg
body weight) and were killed either 90 min or 15 h later for either
epithelial cell proliferation or migration measurements, respectively.
Colon sections were processed for immunohistochemistry and BrdU
staining was detected with a monoclonal anti-BrdU antibody, 1:300
dilution, as previously [5]. The number of labelled cells in 30 long-
itudinally well oriented crypts per mouse was determined by light mi-
croscopy. Epithelial cell proliferation is expressed as the number of
BrdU-positive cells per crypt. The cell migration rate is estimated by
measuring the distance from the base of the crypt to the foremost-la-
belled cell and expressed as μm/h.
2.6. Measurement of cell apoptosis
The apoptotic cells in the colon epithelium were identiﬁed and
quantiﬁed by immunohistochemistry assay of cleaved caspase-3. A
polyclonal anti-cleaved caspase-3 antibody was used at dilution 1:200.
The number of labelled cells in 150 longitudinally well oriented crypts
per mouse was determined by light microscopy. Results are expressed
as the number of labelled cells per 10 crypts.
2.7. Measurement of cell diﬀerentiation
Alcian Blue, Periodic Acid-Shiﬀ (PAS) and the anti-Muc2 antibody
(1:25 dilution) were used to stain acidic, neutral and Muc2 mucins,
respectively. Colonocytes and enteroendocrine cells were identiﬁed by
immunohistochemical detection of carbonic anhydrase-1 and chromo-
granin A, respectively. The number of labelled cells was determined in
at least 30 crypts longitudinally well oriented per mouse. Results are
expressed as the number of labelled cells per crypt.
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2.8. Morphological studies
The tissues were incubated in phosphate-buﬀered saline solution
(PBS) containing 4% paraformaldehyde at 4 °C overnight. Paraﬃn-
embedded sections (5 μm) of proximal and distal colon, obtained from
wild-type and reeler mice, were stained with hematoxylin and eosin
procedure. Measurements of the diameter and depth of the crypts were
done on at least 30 well oriented, full-length crypts. Morphometric
measurements of the crypts and tumours were performed by Spot
Advance 3.5.4.1. images analysis program (Diagnostic Instrument,
Inc.).
2.9. Electron microscopy studies
Segments of distal colon were ﬁxed in 4% glutaraldehyde/0.1 mol/l
sodium cacodylate, pH 7.4 at 4 °C for 3 h. After three rinses in caco-
dylate-buﬀered solution, the tissues were postﬁxed in 1% OsO4 in 0.1 M
phosphate buﬀer at 4 °C for 1 h and washed in cacodylate-buﬀered
solution containing 7.5% sucrose. The segments were then dehydrated
in a graduated series of acetone (30%, 50% and 70%), stained with 2%
uranyl acetate and embedded in Spurr's epoxy resin. Ultrathin sections
(80–100 nm) were examined under a Philips CM-10 transmission
electron microscope equipped with an Olympus Veleta camera. The
photographs were processed with iTEM software and ImageJ program
version 1.46 (National Institutes for Health, http://rsb.info.nih.gov/ij/
index.html).
2.10. Relative quantiﬁcation of Real-time PCR
Total RNA was extracted from the colon using RNeasy® kit (Qiagen,
Hilden, Germany). RNA purity was assessed by spectrophotometry
measurements of OD260/280 and its integrity by visual inspection after
electrophoresis on an agarose gel in the presence of RedSafe™ (Intron
Biotechnology) nucleic acid staining. cDNA was synthesized from 1 μg
of total RNA using QuantiTect® reverse transcription kit (Qiagen) as
described by the manufacturer. The primers used are given in Table 1.
Real-time PCR was performed with 10 μl SsoFast™ EvaGreen® Supermix
(BioRad), 0.4 μM primers and 1 μl cDNA. Controls were carried out
without cDNA. Ampliﬁcation was run in a MiniOpticon™ System
(BioRad) thermal cycler (95 °C/3 min; 35 cycles of 94 °C/40 s, 58 °C/
40 s and 72 °C/40 s, and 72 °C/2 min). Following ampliﬁcation, a
melting curve analysis was done by heating the reactions from 65 to
95 °C in 1 °C intervals while monitoring ﬂuorescence. Analysis con-
ﬁrmed a single PCR product at the predicted melting temperature. β-
Actin served as reference gene and was used for samples normalization.
The cycle at which each sample crossed a ﬂuorescence threshold, Ct,
was determined and the triplicate values for each cDNA were averaged.
Analyses of PCR were done using the comparative Ct method with the
Gene Expression Macro software supplied by BioRad.
2.11. Statistical analysis
Data are presented as mean ± SEM. Comparisons between dif-
ferent experimental groups were evaluated by the two-tailed Student's t-
test. One-way ANOVA followed by the Newman–Keuls' test was used for
multiple comparisons (GraphPad Prism program). Diﬀerences were set
to be signiﬁcant for p < 0.05.
3. Results
3.1. Absence of reelin and the homeostasis of the colon epithelium
To test whether the increased susceptibility of the reeler mice to
DSS-colitis was associated with epithelial barrier defects, we ﬁrst de-
termined whether reelin contributes to the homeostasis of the crypt/
surface axis of the colon. This was achieved by evaluating the cell
proliferation, migration, diﬀerentiation and apoptosis of proximal and
distal colon epithelium of 1 month-old wild-type and reeler mice.
BrdU incorporation into DNA was measured to determine the eﬀects
of the reeler mutation on epithelial cell proliferation and migration
rates, as described in Methods. The results show that at 90 min after
injection, BrdU is mainly observed in the nuclei of the cells located in
the ﬁrst third of the crypts of both types of mice (Fig. 1A). At 15 h after
the injection, the BrdU positive cells occupy nearly the full length of the
crypt in the wild-type mice, but only the lower half of the crypts in the
reeler mice (Fig. 1B). The quantiﬁcation of the marked nuclei reveals
that in the wild-type mice the cell proliferation and migration rates are
greater in the distal than in the proximal colon and that the mutation
signiﬁcantly decreases cell proliferation (by 47.5 ± 4.9% and
55 ± 3.2% in proximal and distal colon, respectively) and migration
(by 33 ± 3.2% and 20.4 ± 2.4% in proximal and distal colon, re-
spectively).
Cell apoptosis, evaluated by immunological detection of cleaved
caspase-3, is only observed at the surface epithelium in both types of
mice and colon segments. In wild-type mice, the number of apoptotic
cells is higher in the distal than in the proximal colon and the reeler
mutation signiﬁcantly decreases the number of apoptotic cells in the
distal colon (Fig. 1C). The mutation does not signiﬁcantly aﬀect
apoptosis in the proximal colon.
Cell diﬀerentiation into goblet cells was evaluated by detection of
acid (Alcian blue), neutral (PAS) and Muc2 (anti-Muc2 antibody) mu-
cins. The staining of the three mucins is lower in the reeler colon epi-
thelium as compared with the wild-type colon (Fig. 2A). The quantiﬁ-
cation of PAS- and Muc2- positive cells (Fig. 2B) reveals that the
number and maturation of goblet cells, respectively, are higher in the
distal than in the proximal colon of wild-type mice and that they di-
minish in the reeler mice. PAS positive cells are reduced by 38 ± 5.5%
in the proximal and by 70 ± 4.8% in the distal colon and Muc2 po-
sitive cells are reduced by 21 ± 2% in the proximal colon and by
Table 1
Oligonucleotides sequences used for real time PCR.
Gene Accession no. Sense (5′- 3′) Antisense (5′- 3′)
β-actin NM_007393 ACCCACACTGTGCCCATCTA CGGAACCGCTCATTGCC
Atoh1 NM_007500 GTATCTGCTGCATTCTCCCGA CAAGCTCGTCCACTACAACC
Cdx2 NM_007673 AACTACAGGAGCCAGAGGCA AGGGACAGGAAGTCCAGGTT
Cyclin D1 NM_007631 AGGCTACAGAAGAGTATTTATGGGAA TGCGTTTGAATCAAGGGAGAT
Hes1 NM_008235 TCAACACGACACACGGACAAACC GGTACTTCCCCAACACGCTCG
IFNγ NM_008337 CAGCAACAGCAAGGCGAAA CTGGACCTGTGGGTTGTTGAC
IL-6 NM_031168 ACAAGTCGGAGGCTTAATTACACAT TTGCCATTGCACAACTCTTTTC
Smad5 NM_021692 GACAGCAGCATCTTTGTTCAG ATCCATGGTTGACTGACTGAG
Sox9 NM_011448 TCGTGTGTGTGTGTTTATAG ATTCCTATTGCTACACTCAG
Oligonucleotides were chosen according to cDNA sequences entered in GenBank and designed using PerlPrimer program v1.1.14. Atoh1, Atonal homolog-1; Cdx2, Caudal-type homeobox
transcription factor 2; Hes1, Hairy and enhancer of split-1; IFNγ, Interferon γ; IL-6, Interleukin-6; Smad5, Mothers against decapentaplegic, drosophila, homolog of, 5; Sox9, SRY-related
HMG-box, gene 9.
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55 ± 3% in the distal colon. The number of Alcian blue stained cells
was not evaluated because of the diﬃculty to be counted.
As the changes induced by the mutation on cell diﬀerentiation are
higher in the distal than in the proximal colon, the terminal diﬀer-
entiation into colonocytes and enteroendocrine cells was evaluated only
in the distal colon. Carbonic anhydrase-1 and chromogranin A were
chosen as markers of colonocytes and enteroendocrine cells, respec-
tively. Fig. 3 shows that in both, wild-type and reeler mice the carbonic
anhydrase-1 positive cells are mainly located at the surface epithelium
whereas the chromogranin A positive cells are dispersed within the
crypts. Fig. 3 also reveals that carbonic anhydrase-1 immunostaining
and the number of chromogranin A positive cells in the reeler colon is
lower than in the wild-type colon. The number of enteroendocrine cells
per crypt decreases by 45.5 ± 9% in the reeler mice as compared with
the wild-type mice. The number of carbonic anhydrase-1 positive cells
was not evaluated because of counting diﬃculty.
The ﬁndings discussed so far indicate that the magnitudes of the
epithelium cell renewal processes are higher in the distal than in the
proximal colon and that they are decreased by the reeler mutation.
3.2. Morphology of the colon in wild-type and reeler mice
We next examined whether the changes induced by the mutation in
epithelial cell proliferation, migration, diﬀerentiation and apoptosis are
translated to changes in the gross morphology of the colon. The depth
and diameter of the crypts were measured by light microscopy in he-
matoxylin and eosin stained sections of colon of 1 and 3 month-old
mice. Table 2 reveals that the crypts are deeper in the distal colon than
in the proximal in both, wild-type and reeler mice. The crypts diameter
is signiﬁcantly greater in the distal than in the proximal colon only in
the three month-old wild-type mice. The reeler mutation decreases the
weight and length of the colon (Fig. 4) and the depth of the crypts. The
mutation signiﬁcantly reduces the diameter of the crypts only in the
distal colon (Table 2 and Fig. 4).
Examination at the electron microscope of the surface epithelium of
distal colon reveals larger and thinner microvilli in the reeler than in
the wild-type mice (Fig. 5A). The photographs also show that the tight
and the adherens junctions appear normal but the intercellular space of
desmosomes is signiﬁcantly wider in the reeler than in the wild-type
mice (Fig. 5B).
3.3. mRNA abundance of Sox9, Cdx2, Cyclin D1, Smad5, Hes1 and Atoh1
in the colon of wild-type and reeler mice with or without DSS-treatment
To get some insight into the molecular mechanisms by which reelin
regulates colon epithelium homeostasis and reduces the response to
experimentally induced colon pathology, we next evaluated the mRNA
abundance of Sox9, Cdx2, Hes1, Atoh1, Cyclin D1 and Smad5. In the
intestinal epithelium Sox9, Cdx2, Hes1 and Atoh1 control the cell
proliferation, diﬀerentiation and fate decision of stem/proliferator cells
to either absorptive or secretory cells [13]. Smad5 was chosen because
its absence induces modiﬁcations in the apical junctions [14] similar to
those previously observed in the intestine of the reeler mice [5] and
Cyclin D1 was tested because it controls cell replication [15]. The
measurements were made in the distal colon of DSS-treated and un-
treated wild-type and reeler mice. The results in Fig. 6A reveal that
under not inﬂammatory conditions (DSS-untreated mice) the mutation
signiﬁcantly decreases Sox9 and Cdx2 mRNA levels, without aﬀecting
Fig. 1. Cell proliferation, migration and apop-
tosis in colon epithelium of wild-type and reeler
mice. 7 μm cryosections of the colon were ob-
tained from 1 month-old wild-type and reeler
mice. The sections were immunostained with
anti-BrdU antibody (1:300 dilution) for pro-
liferation [A] and migration [B] assays and with
anti-caspase 3 antibody (1:200 dilution) for
apoptosis measurements [C]. Mice were killed
either 90 min or 15 h after BrdU injection for cell
proliferation and migration measurements, re-
spectively. In B, lines indicate the front point of
labelled cells used to evaluate cell migration rate,
expressed in μm/h. In C, arrows indicate caspase
3 labelled cells. Scale bar represents 50 μm. The
number of BrdU-labelled cells was determined in
30 crypts and those labelled with anti-caspase 3
antibody in 150 crypts per mouse. Histograms
represent means ± SEM. Five reeler and ﬁve
wild-type mice were used. One-way ANOVA
showed an eﬀect of mutation and colon region on
the cell proliferation, migration and apoptosis
(p < 0.001). Newman–Keuls' test: *p < 0.001
reeler vs. wild-type mice and #p < 0.001 distal
vs. proximal colon.
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the others genes tested, suggesting that the down-regulation of Sox9
and Cdx2 might contribute to the reeler phenotype of the colon epi-
thelium.
The results obtained in response to DSS-treatment are given in
Fig. 6B as the ratio of the mRNA levels measured in the DSS-treated vs.
those in DSS-untreated mice. They show that DSS-treatment reduces
Cdx2, Hes1 and Atoh1 mRNA levels and increases those of Sox9, but
these changes are of similar magnitude in both types of mice. DSS-
treatment up-regulates Smad5 and Cyclin D1 in the reeler colon,
whereas in the wild-type mice, it decreases Smad5 mRNA abundance
and does not change that of Cyclin D1 mRNA.
3.4. Cytokines expression in the colon of DSS-treated wild-type and reeler
mice
The mRNA abundance of the proinﬂammatory cytokines inter-
leukin-6 [IL-6] and interferonγ [IFNγ] was evaluated in the DSS-treated
mice colon and the results reveal that the reeler mutation increases the
mRNA abundance of IL-6 from 3.3 ± 1 in wild-type to 79 ± 20 in the
reeler mice (p < 0.01, n = 5) and decreases that of IFNγ from
35.6 ± 9 in wild-type to 2.6 ± 1 (p < 0.01, n = 5) in reeler mice.
3.5. AOM/DSS-induced tumour development in wild-type and reeler mice
It is well known that chronic ulcerative colitis is associated with an
Fig. 2. Number and maturation of goblet cells in colon
epithelium of wild-type and reeler mice. 5 μm paraﬃn-
embedded colon sections of 1 month-old wild-type and
reeler mice were stained for acidic, neutral and Muc2
mucins with Alcian blue, PAS and anti-Muc2 antibody
(1:50 dilution), respectively. A, Representative stained
goblet cells in the distal colon are shown. Scale
bar = 50 μm. B, Histograms represent means ± SEM
of the number of PAS- and Muc2-positive cells per
crypt. Five reeler and ﬁve wild-type mice were used.
One-way ANOVA showed an eﬀect of mutation on the
cell diﬀerentiation and maturation of goblet cells and
colon region (p < 0.001). Newman–Keuls' test:
*p < 0.001 reeler vs. wild-type mice and #p < 0.001
distal vs. proximal colon.
Fig. 3. Cell diﬀerentiation into colonocytes and
enteroendocrine cells in wild-type and reeler
mice. 5 μm paraﬃn colon sections were im-
munostained for carbonic anhydrase-1 and chro-
mogranin A using anti-carbonic anhydrase-1
(1:50 dilution) and anti-chromogranin A (1:100
dilution) antibodies, respectively. Arrows in-
dicate labelled cells. Representative specimens
are shown. Scale bar = 50 μm. Histogram re-
presents means ± SEM of the number of en-
teroendocrine labelled cells per crypt. Five reeler
and ﬁve wild-type mice were used. Student's t-
test: *p < 0.001 reeler vs. wild-type mice.
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increased risk to develop colorectal cancer and these conditions have
been reproduced in the current study to test whether reelin provides
resistance to tumour development. We examined the susceptibility to
colon tumorigenesis of wild-type and reeler mice subjected to AOM/
DSS-treatment, as described in Methods. Both types of mice developed
tumours in the distal colon with a 100% incidence and the hematoxylin
and eosin stained tumour sections reveal that all the tumours analysed
have adenocarcinoma appearance (Fig. 7C). The results also reveal that
the reeler mice are more sensitive to colitis-associated tumorigenesis
than wild-type mice, because they exhibit higher mortality during the
AOM/DSS treatment (20% vs. 0% in wild-type mice) and increased
average of tumours number and size as compared with the wild-type
mice. Tumours larger than 3 mm of diameter are only observed in reeler
mice (Fig. 7A and B). These observations indicate that the reeler mu-
tation enhances colitis-associated tumours promotion.
4. Discussion
Several gastrointestinal and extra-intestinal diseases have been as-
sociated with disruption of the gut barrier and we show here that reelin
protection against colon pathology could be due to its contribution to
the maintenance of the intestinal barrier integrity. Thus the mutation: i)
decreases the magnitude of the epithelial cell proliferation, migration,
diﬀerentiation and apoptosis; ii) expands the desmosomes intercellular
space, and iii) decreases the length of the crypts. The decreased epi-
thelial cell proliferation would slow epithelium renewal and even bar-
rier restoration following injury. The diminution in goblet cells diﬀer-
entiation and maturation, the latter indicated by the decrease in Muc2
staining, would impair the mucus layer, and defects in renewal and
formation of the inner mucus layer allow bacteria to reach the epithe-
lium and have implications for the causes of colitis [16]. In addition,
goblet cells participate in intestinal immune homeostasis by delivering
low molecular weight antigens from the intestinal lumen to underlying
dendritic cells [17]. The decrease in cell apoptosis would increase the
exposition time of colonocytes to deleterious or mutagenic agents and
therefore increase the epithelium susceptibility to damage. The muta-
tion-induced alteration of the desmosomes might indicate dis-
assembling of the junction, which in turn may impair the intestinal
barrier [18], an eﬀect that would be worsened by the colitis-induced
neutrophil inﬁltration. Some studies recognize a role for the desmo-
somes in tumour suppression [19], in inﬂammatory bowel diseases
development [20] and in the shape of the microvilli [21]. The phy-
siological meaning of the mutation-induced changes in the microvilli
shape is not evident, though microvilli membrane is the site of transport
proteins and enzymes. Finally, the mutation-related decrease in the
length of the crypts will reduce the thickness of the mucosa. All these
observations indicate that the absence of reelin weakens the intestinal
barrier and therefore the intestinal defense against the broad spectrum
of potentially lethal microorganisms and carcinogens present in the
intestinal lumen (see [1] for a review).
The current work also shows that in the wild-type mice, the mag-
nitude of the epithelium renewal processes and the length of the crypts
are in the distal colon greater than in the proximal. Similar regional
diﬀerences in cell proliferation [22] and length of the crypts [23] have
been reported. These regional diﬀerences might be related to their
physiological functions. The distal colon absorbs ﬂuid against a high
hydraulic resistance in the lumen, whereas the proximal is unable to do
this, and the larger suction tension requires longer crypts [24].
The mechanistically complex colon epithelium homeostasis, main-
tained by the interplay of various signalling pathways, that maintains
the balance between proliferation, diﬀerentiation and apoptosis, is still
being uncovered. We have evaluated the eﬀect of the mutation on the
expression of Sox9, Cdx2, Hes1 and Atoh1, genes known to regulate the
dynamics of the crypt/surface unit [13]. We found that the reeler
mutation does not modify the mRNA levels of Hes1 and Atoh1 but
decreases those of Sox9 and Cdx2, suggesting that the down-regulation
of the two genes may contribute to establish the reeler phenotype of the
colon epithelium. The observations agree with those showing variations
in Sox9 expression in the same direction as epithelial cell proliferation
[25–27] and goblet cells diﬀerentiation and maturation [28], and with
reports revealing that Cdx2 activates genes of diﬀerentiated colono-
cytes, such as carbonic anhydrase-1 [29], and of diﬀerentiated goblet
cells, such as Muc2 [30]. The components of the reelin signalling
system have been studied intensively in the central nervous system, but,
as far as we are aware, no relation between reelin and these two genes
has been described with the exception of a report showing that absence
of reelin decreases Sox9 expression in digit mesoderm cell cultures
[31].
DSS-treatment increases Sox9 mRNA abundance and decreases that
of Cdx2, Hes1 and Atoh1 to the same proportion in both types of mice,
indicating that the changes are due to DSS-treatment by itself. Smad5
and Cyclin D1 were diﬀerently expressed in DSS-treated wild-type and
reeler mice. DSS-treatment decreases Smad5 mRNA abundance and
Table 2
Morphometric parameters of wild-type and reeler mice colon.
Mice Crypt depth Crypt diameter
Proximal Distal Proximal Distal
1 month-old
Wild-type: 93.3 ± 3 165.1 ± 3# 29.8 ± 1 32.1 ± 1.8
Reeler: 78.8 ± 2* 132.8 ± 3*# 29.1 ± 0.8 25.6 ± 1.1*
3 month-old
Wild-type: 126.3 ± 6 251.9 ± 12# 36.5 ± 1.9 47.0 ± 1.3#
Reeler: 87.6 ± 2.5* 183.6 ± 3.4*# 36.2 ± 1.8 37.6 ± 1.2*
Means ± SEM of colon measurements (in μm). Five reeler and ﬁve wild-type mice per
age were used. One-way ANOVA showed an eﬀect of the colon region and mutation on
colon morphology (p < 0.001). Newman–Keuls' test: *p < 0.001 reeler vs. wild-type
mice; #p < 0.001 proximal vs. distal colon.
Fig. 4. Colon weight and length of wild-type and re-
eler mice. 1 month and 3 month-old wild-type and
reeler mice were used. Data are presented as the
means ± SEM of ﬁve diﬀerent animals per age and
type of mouse. The photograph represents the cecum
and colon of wild-type and reeler mice. Blue, red and
green lines represent the length of the cecum, prox-
imal and distal colon, respectively. One-way ANOVA
showed an eﬀect of mutation on colon weight and
length (p < 0.001). Newman–Keuls' test:
*p < 0.001 and **p < 0.01 reeler vs. wild-type
mice.
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produces no change on that of Cyclin D1 in wild-type mice, but in-
creases the mRNAs levels of both genes in the reeler mice, suggesting
that reelin signalling represses Smad5 and Cyclin D1. Recent studies
have associated activation of Smad5 and Cyclin D1 with cancer.
Activation of Smad5 has been observed in several cancers, including
colon cancer [32]. Activation of the proto-oncogene Cyclin D1 has been
found in ulcerative colitis and colorectal carcinoma [33–35] and its loss
or reduction reduces intestinal tumour formation in mice carrying
mutations that develop intestinal adenomas [36]. IL-6 and IFNγ were
also diﬀerently expressed in both types of mice. DSS-treated reeler mice
exhibit higher IL-6 mRNA levels and lower IFNγmRNA levels than DSS-
treated wild-type mice. IL-6 is a proinﬂammatory cytokine associated
with colon cancer [37–39] and contributes to the formation of a tumour
supportive microenvironment that increases the propensity of human
ulcerative colitis to malignant transformation [40]. The reduced IFNγ
mRNA levels observed in the reeler mice were at ﬁrst unexpected
because it is considered as a proinﬂammatory cytokine. However, IFNγ
production is essential for antitumour immunity in colon [41–43]. In
line with the protumorigenic phenotype observed in the reeler mice,
intestinal reelin appears to be protective against tumorigenesis induced
by chemical agents. Thus in response to AOM/DSS-treatment, the reeler
mice colon develops higher number of tumours and of bigger size than
the wild-type. These observations agree with our previous one in
human colon [7] and with that of Castellano et al. [44] showing that
increased levels of reelin are related with reduced lung tumorigenesis in
mice.
Together the observations suggest that reelin provides protection
from worsening the acute colon inﬂammation and/or from progression
to cancer development by reducing the response of Smad5, Cyclin D1,
IL-6 and IFNγ to DSS-treatment. As reelin deletion alone is not suﬃcient
to initiate colon pathology in the mouse, because the reeler mice re-
main pathology-free up to 15 months of age [5], we propose that in
Fig. 5. Electron microscopy of the apical domain of
control and reeler colon epithelium. A, Microvilli (M)
of colon epithelium are shown. Scale bar = 1000 nm.
B, Apical cell-to-cell junctions. TJ, tight junction; AJ,
adherens junction; D, desmosome. 25 to 30 junctions
were examined per type of mouse. Scale
bar = 200 nm. The histograms represent
means ± SEM of microvilli width or length, and of
junction width. The microphotographs are re-
presentative of three diﬀerent assays performed on
ﬁve reeler and ﬁve wild-type mice of 3 month-old.
Student's t-test: *p < 0.001 reeler vs. wild-type mice.
Fig. 6. mRNA levels of Sox9, Cyclin D1, Cdx2, Smad5,
Hes1 and Atoh1 in the colon epithelium of wild-type
and reeler mice with or without DSS-treatment. Mice
of 3 month-old received 3% DSS in the drinking water
during 9 days, as described in Methods. A, mRNA re-
lative abundance in DSS-untreated wild-type and re-
eler mice. B, The histograms represent the mRNA
abundance fold change produced by DSS-treatment
relative to DSS-untreated-mice. Data are
means ± SEM. The number of animals used was ﬁve
reeler and ﬁve wild-type mice. One way ANOVA re-
vealed an eﬀect of the mutation and of DSS-treatment
on mRNA abundance of the genes tested (p < 0.001).
Newman–Keuls' test: ap < 0.001 and bp < 0.01 DSS-
treated vs. untreated mice; *p < 0.01, **p < 0.05
reeler vs. wild-type mice.
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response to challenges, such as inﬂammation, reelin increases to re-
inforce intestinal barrier integrity, facilitate tissue repair and suppress
activation of tumorigenic genes. If acute colitis progresses to conditions
that reduce or suppress reelin expression, then the absence of reelin
favors the formation of a tumour supportive microenvironment that
would worse inﬂammation and/or induce tumorigenesis.
In summary, the current results highlight an essential role for reelin
in maintaining intestinal epithelial cell homeostasis and providing re-
sistance against colon pathology. They also suggest that Sox9, Cdx2,
Smad5, Cyclin D1, IL-6 and IFNγ might function as downstream med-
iators of the reelin signalling.
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